Tag: Pegfilgrastim

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Pegfilgrastim

On Feb 2, 2019 Coherus Biosciences Inc (NASDAQ:CHRS) Sellers Increased Their Shorts By ...

Added to Collection on: 2019-02-02 04:37:30

Tags for this article:

Health
Medicine
Biotechnology
Recombinant proteins
Autoimmune diseases
Biopharmaceutical
TNF inhibitors
Immunosuppressants
Adalimumab
Etanercept
Psoriatic arthritis
Pegfilgrastim

Click the tags to see associated articles and topics

View Article Details
On March, 14 Coherus BioSciences, Inc. (CHRS) Analysts See $-0.82 EPS

Added to Collection on: 2019-02-10 14:12:22

Tags for this article:

Medicine
RTT
Rheumatology
Arthritis
Autoimmune diseases
Biopharmaceutical
TNF inhibitors
Adalimumab
Etanercept
Life Sciences
Pegfilgrastim
Medical specialties

Click the tags to see associated articles and topics

View Article Details
EPS for Coherus BioSciences, Inc. (CHRS) Expected At $-0.82 as of March, 14

Added to Collection on: 2019-02-10 14:11:15

Tags for this article:

Medicine
Clinical medicine
RTT
Rheumatology
Arthritis
Autoimmune diseases
Biopharmaceutical
TNF inhibitors
Adalimumab
Etanercept
Pegfilgrastim
Medical specialties

Click the tags to see associated articles and topics

View Article Details
$-0.82 EPS Expected for Coherus BioSciences, Inc. (CHRS)

Added to Collection on: 2019-02-17 13:15:00

Tags for this article:

Medicine
Recombinant proteins
Rheumatology
Arthritis
Biopharmaceutical
TNF inhibitors
Immunosuppressants
Adalimumab
Etanercept
Life Sciences
Pegfilgrastim
Medical specialties

Click the tags to see associated articles and topics

View Article Details
Coherus Biosciences Inc (NASDAQ:CHRS) Shares Shorted Rose By 21.19%

Added to Collection on: 2019-02-26 02:44:14

Tags for this article:

Health
Medicine
Recombinant proteins
Rheumatology
Arthritis
Biopharmaceutical
TNF inhibitors
Immunosuppressants
Adalimumab
Etanercept
Pegfilgrastim
Medical specialties

Click the tags to see associated articles and topics

View Article Details
European Commission Approves Pfizer's Pegfilgrastim Biosimilar

Added to Collection on: 2020-11-23 13:18:45

Tags for this article:

Life Sciences
Health care
Biotechnology
Amgen
Recombinant proteins
Pegfilgrastim
Biosimilar
Growth factors
Filgrastim
Biopharmaceutical
Pfizer
Mylan

Click the tags to see associated articles and topics

View Article Details
Using Secondary Patents and Skinny Labels

Added to Collection on: 2021-04-13 12:00:00

Tags for this article:

Life Sciences
Amgen
Recombinant proteins
Health care
Biotechnology
Drugs
Biosimilar
Filgrastim
Pegfilgrastim
Patent
Bhavesh Shah

Click the tags to see associated articles and topics

View Article Details
Health Canada approves Lupin's biosimilar version of Pegfilgrastim

Added to Collection on: 2024-08-24 17:10:20

Tags for this article:

Amgen
Recombinant proteins
Biopharmaceuticals
Biosimilar
Growth factors
Lupin Limited
Pegfilgrastim
Filgrastim
LUPIN Ltd
Canada

Click the tags to see associated articles and topics

View Article Details
Accord BioPharma, Inc. Announces Completion of UDENYCA® (pegfilgrastim-cbqv ...

Added to Collection on: 2025-04-15 15:49:50

Tags for this article:

Amgen
Recombinant proteins
Pegfilgrastim
Intas Pharmaceuticals
Biosimilar
Filgrastim
Accord
Biopharmaceutical
Pharmaceutical industry in India
Ranibizumab
Intas Pharmaceuticals, Ltd.
Accord BioPharma
United States
Accord BioPharma Inc.

Click the tags to see associated articles and topics

View Article Details
Intas Pharmaceuticals, Accord BioPharma acquires UDENYCA - IndiaMedToday

Added to Collection on: 2025-08-08 18:31:11

Tags for this article:

Recombinant proteins
Pegfilgrastim
Intas Pharmaceuticals
Biosimilar
Filgrastim
Accord
Neulasta
Coherus Biosciences Inc.
United States

Click the tags to see associated articles and topics

View Article Details
Book a Demo